Overall, findings demonstrate reduced baseline hepatic glucose production, impaired insulin sensitivity with lower rate of glucose infusion to achieve euglycemia, and suppression of endogenous hepatic glucose production in response to hyperinsulinemia in the steady-state. Here, INS is linked to hyperinsulinism.